Radiation for leftover spots after chemo-immunotherapy in lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial is for people with extensive-stage small cell lung cancer. After standard chemo-immunotherapy, it tests whether giving radiation to all remaining tumor spots can improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with extensive-stage small cell lung cancer (cancer that has spread beyond one lung).
- You are able to carry out your daily activities with little or no help (ECOG score 0 or 1).
- Your liver, kidneys, and bone marrow are working well enough to handle chemotherapy, immunotherapy, and radiation.
- You have signed a consent form agreeing to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding radiation therapy to the chest during maintenance immunotherapy can help people with extensive-stage small cell lung cancer live longer. You may be eligible if you've already had chemotherapy plus immunotherapy and your cancer has shrunk or stayed stable.
This trial tests a combination of an immunotherapy drug (tislelizumab) with chemotherapy and chest radiation for people with extensive-stage small cell lung cancer (SCLC) that has spread. The goal is to see if this combination helps shrink or control the cancer longer.
This study tests using a shorter course of radiation (hypofractionated radiotherapy) combined with immunotherapy for people with limited-stage small-cell lung cancer. The goal is to see if this approach works better at controlling the cancer and may cause fewer side effects.
This trial tests whether giving focused radiation to remaining spots of lung cancer (after standard treatment) can help prevent cancer from growing back. It may be an option if you have had 4-6 cycles of chemo plus immunotherapy and still have a few active spots.
This trial looks at whether giving additional targeted radiation to the chest can help people with extensive-stage small cell lung cancer after they finish standard chemo-immunotherapy. It may help control the cancer in the lung area and prevent it from coming back there.
This trial tests a combination of chemotherapy, immunotherapy, and targeted radiation for people with extensive-stage small-cell lung cancer. The goal is to see if adding radiation to leftover tumors after initial treatment helps control the disease better.
Hear when a new Small Cell Lung Cancer Extensive Stage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.